Covered recipient · General Payments record
BLAKE JOSEPH LEBLANC
Allopathic & Osteopathic Physicians Otolaryngology
General Payments · PY2018–2024
$3,985.71
- Reported across 162 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $333.78 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $161.80 | 4 |
| Regeneron Healthcare Solutions, Inc. | $63.69 | 2 |
| OptiNose US, Inc. | $49.73 | 3 |
| Hikma Pharmaceuticals USA | $23.64 | 1 |
| AERIN MEDICAL INC. | $17.74 | 1 |
| Kaleo, Inc. | $17.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AERIN MEDICAL INC. | $17.74 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144646762 | CMS |
| GENZYME CORPORATION | $46.99 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139818665 | CMS |
| GENZYME CORPORATION | $28.89 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139818707 | CMS |
| GENZYME CORPORATION | $47.10 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139818725 | CMS |
| GENZYME CORPORATION | $38.82 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139818731 | CMS |
| Hikma Pharmaceuticals USA | $23.64 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127502733 | CMS |
| kaleo, Inc. | $17.18 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126623220 | CMS |
| Optinose US, Inc. | $17.02 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142193204 | CMS |
| Optinose US, Inc. | $14.51 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142193210 | CMS |
| Optinose US, Inc. | $18.20 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142193220 | CMS |
| Regeneron Healthcare Solutions, Inc. | $34.75 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114097375 | CMS |
| Regeneron Healthcare Solutions, Inc. | $28.94 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114097377 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.